BioSpace News Archive

Cortexyme, Inc. announced it is initiating an open-label extension study in the United States for its Phase 2/3 GAIN Trial of COR388 in subjects with mild to moderate Alzheimer’s disease.

Veravas, Inc. and Tymora Analytical Operations, LLC announced that they have entered into a strategic alliance to explore the integration of their respective technologies.

Following discussions with the Company, the ANSM decision to allow new patient recruitment to resume in Sézary syndrome and MF in France is based on an assessment of the unmet medical need and the lack of currently available standard of care options.

Innovent Biologics, Inc. announced that the Company has entered into an out-license agreement with Coherus BioSciences, Inc., a leading biosimilar company that develops and commercializes its own high-quality therapeutics as well as those of others seeking capable access to the United States market, to commercialize Innovent’s biosimilar candidate to Avastin® in the United States and Canada.

Biotin’s upsurge in popularity has led to a parallel rise in incidents of this health supplement interfering with critical medical tests.

Neptune Wellness Solutions Inc. (“Neptune” or the “Company”) (Nasdaq: NEPT) (TSX: NEPT), a health and wellness company focused on extraction, purification and formulation of cannabinoids, would like to provide an update on its non-core investments.

etectRx™, Inc. (etectRx™), a privately-held digital health company, today announced the ID-Cap™ System is being utilized in a clinical study of 180 patients to create a reliable record of adherence for over 20,000 doses of HIV medication.

Mr. DiPofi brings vast experience to 50 year old company experiencing a resurgence in market share.

Triple-drug regimen shown to be superior to conventional treatment in major multicenter study presented at American Society of Hematology annual meeting

The opening of Porton’s biocatalysis technology lab and fermentation facility at its Changshou site in Chongqing builds on its previous strategic investments in biocatalysis, and its partnership with Codexis.